AMN Healthcare (AMN) Reports Q4 Earnings: What Key Metrics Have to Say

For the quarter ended December 2025, AMN Healthcare Services (AMN) reported revenue of $748.23 million, up 1.8% over the same period last year. EPS came in at $0.22, compared to $0.75 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $723.87 million, representing a surprise of +3.37%. The company delivered an EPS surprise of -1.12%, with the consensus EPS estimate being $0.22.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how AMN Healthcare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenue- Physician and leadership solutions: $169.55 million versus the three-analyst average estimate of $168.5 million. The reported number represents a year-over-year change of -2.1%.
• Revenue- Nurse and allied solutions: $490.71 million compared to the $465.36 million average estimate based on three analysts. The reported number represents a change of +7.9% year over year.
• Revenue- Technology and workforce solutions: $87.96 million versus $89.97 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -17.7% change.
• Segment operating income- Nurse and allied solutions: $36.48 million compared to the $32.42 million average estimate based on two analysts.
• Segment operating income- Technology and workforce solutions: $24.9 million versus $29.93 million estimated by two analysts on average.
• Segment operating income- Physician and leadership solutions: $12.92 million versus $13.8 million estimated by two analysts on average.

View all Key Company Metrics for AMN Healthcare here>>>

Shares of AMN Healthcare have returned -11.5% over the past month versus the Zacks S&P 500 composite's -0.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

 
AMN Healthcare Services Inc (AMN): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research